Prophylactic antibiotics in prostate biopsy: A meta-analysis based on randomized controlled trials

Surgical Infections

Volumn 16, Issue 6, 2015, Pages 733-747

  Yang, Lu ^a   Gao, Liang ^a   Chen, Yongji ^a   Tang, Zhuang ^a   Liu, Liangren ^a   Han, Ping ^a   Zeng, Hao ^a   Li, Xiang ^a   Wei, Qiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PIPERACILLIN PLUS TAZOBACTAM; PLACEBO; QUINOLONE DERIVATIVE; SULFONAMIDE; ANTIINFECTIVE AGENT;

ABDOMINAL CRAMP; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BACTERIURIA; COMPLICATION; DIARRHEA; DRUG EFFICACY; FEVER; HOSPITALIZATION; HUMAN; INFECTION RISK; MALE; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; PROSTATE BIOPSY; PRURITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS; SHORT COURSE THERAPY; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TRANSRECTAL PROSTATE BIOPSY; TREATMENT OUTCOME; URINARY TRACT INFECTION; ADULT; ADVERSE EFFECTS; BACTERIAL INFECTIONS; BIOPSY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROCEDURES; PROSTATE; PROSTATIC DISEASES; SURGERY;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; BIOPSY; HUMANS; MALE; PLACEBOS; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSTATE; PROSTATIC DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84948699606     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2015.040     Document Type: Article

References (50)

1. Wagenlehner FM, van Oostrum E, Tenke P, et al. Infective complications after prostate biopsy: Outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. Eur Urol 2013;63:521-527.
2. Carmignani L, Picozzi S, Spinelli M, et al. Bacterial sepsis following prostatic biopsy. Int Urol Nephrol 2012;44:1055-1063.
3. Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol 2013; 64: 876-892.
4. Grabe M, Bartoletti R, Bjerklund-Johansen TE, et al. Guidelines on urological infections. Eur Urol 2014: 81.
5. Wolf JS Jr, Bennett CJ, Dmochowski RR Hollenbeck BK, Pearle MS, Schaeffer AJ. Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel: Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 2008;179:1379-1390.
6. El-Hakim A, Moussa S. CUA guidelines on prostate biopsy methodology. Can Urol Assoc J 2010;4:89-94.
7. Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, Pepin J. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: Time to reassess antimicrobial prophylaxis? Eur Urol 2012; 62: 453-459.
8. Nam RK, Saskin R, Lee Y, et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010; 183:963-968.
9. Feliciano J, Teper E, Ferrandino M, et al. The incidence of fluoroquinolone resistant infections after prostate biopsy- are fluoroquinolones still effective prophylaxis? J Urol 2008; 179:952-955.
10. Batura D, Rao GG, Bo Nielsen P, Charlett A. Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates. BJU Int 2011; 107:760-764.
11. Higgins JPT and Green S (editors): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.4 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
12. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyzes: The PRISMA statement. BMJ 2009;339: b2535.
13. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: A randomized controlled study. BJU Int 2000;85:682-685. Aron 2000a
14. Aron M, Rajeev TP, Gupta NP. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: A randomized controlled study. BJU Int 2000; 85:682-685. Aron 2000b
15. Bates TS, Porter T, Gingell JC. Prophylaxis for transrectal prostatic biopsies: A randomized controlled study of intravenous co-amoxiclav given as a single dose compared with an intravenous dose followed by oral co-amoxiclav for 24h. British J Urol 1998;81:529-531.
16. Bosquet Sanz M, Gimeno Argente V, Arlandis Guzman S, et al. Comparative study between tobramycin and tobramycin plus ciprofloxacin in transrectal prostate biopsy prophylaxis. Actas Urologicas Espanolas 2006;30:866-870.
17. Brewster SF, Macgowan AP, Gingell JC. Antimicrobial prophylaxis for transrectal prostatic biopsy: A prospective randomized trial of cefuroxime versus piperacillin/tazobactam. British J Urol 1995;76:351-354.
18. Briffaux R, Coloby P, Bruyere F, et al. Short or long schemes of antibiotic prophylaxis for prostate biopsy. A multicentre prospective randomized study [Antibioprophylaxie courte versus longue pour les biopsies prostatiques. Etude prospective randomisee multicentrique]. Prog Urol 2009;19: 39-46.
19. Brown RW, Warner JJ, Turner BI, et al. Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology 1981; 18:145-148.
20. Cam K, Kayikci A, Akman Y, Erol A. Prospective assessment of the efficacy of single dose versus traditional 3- day antimicrobial prophylaxis in 12-core transrectal prostate biopsy. Int J Urol 2008;15: 997-1001.
21. Chan ES, Lo KL, Ng CF, et al. Randomized controlled trial of antibiotic prophylaxis regimens for transrectal ultrasound- guided prostate biopsy. Chin Med J (Engl) 2012;125: 2432-2435.
22. Cormio L, Berardi B, Callea A, et al. Antimicrobial prophylaxis for transrectal prostatic biopsy: A prospective study of ciprofloxacin vs piperacillin/tazobactam. BJU Int 2002;90:700-702.
23. Crawford ED, Haynes AL Jr, Story MW, Borden TA. Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol 1982;127:449-451.
24. Fong IW, Struthers N, Honey RJ, et al. A randomized comparative study of the prophylactic use of trimethoprimsulfamethoxazole versus netilmicinmetronidazole in transrectal prostatic biopsy. J Urol 1991;146:794-797.
25. Isen K, Kupeli B, Sinik Z, et al. Antibiotic prophylaxis for transrectal biopsy of the prostate: A prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprimsulfamethoxazole. Int Urol Nephrol 1999;31:491-495. Isen 1999a
26. Isen K, Kupeli B, Sinik Z, et al. Antibiotic prophylaxis for transrectal biopsy of the prostate: A prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprimsulfamethoxazole. Int Urol Nephrol 1999;31:491-495. Isen 1999b
27. Kapoor DA, Klimberg IW, Malek GH, et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998;52:552-558.
28. Melekos MD. Efficacy of prophylactic antimicrobial regimens in preventing infectious complications after transrectal biopsy of the prostate. Int Urol Nephrol 1990;22: 257-262.
29. Pace G, Carmignani L, Marenghi C, et al. Cephalosporins periprostatic injection: Are really effective on infections following prostate biopsy? Int Urol Nephrol 2012;44:1065-1070.
30. Petteffi L, Toniazzo GP, Sander GB, et al. Efficiency of short and long term antimicrobial therapy in transrectal ultrasound-guided prostate biopsies. Int Braz J Urol 2002; 28:526-532.
31. Ruebush TK, McConville JH, Calia FM. A double-blind study of trimethoprim-sulfamethoxazole prophylaxis in patients having transrectal needle biopsy of the prostate. J Urol 1979;122:492-494.
32. Schaeffer AJ, Montorsi F, Scattoni V, et al. Comparison of a 3-day with a 1-day regimen of an extended-release formulation of ciprofloxacin as antimicrobial prophylaxis for patients undergoing transrectal needle biopsy of the prostate. BJU Int 2007; 100:51-57.
33. Shivde SR, Cooke RPD, O'Neill WA, et al. Trimethoprim versus Gentamicin for the prevention of bacteriuria following transrectal biopsy of the prostate-do patients need additional anaerobic cover?. Uro Int 2002;69: 106-110.
34. Tekdogan U, Tuncel A, Eroglu M, et al. The efficiency of prophylactic antibiotic treatment in patients without risk factor who underwent transrectal [Transrektal prostat igne biyopsi yapilan risk faktorsuz hastalarda koruyucu antibiyotik tedavisinin etkinligi]. Turk Uroloji Dergisi 2006;32: 261-267.
35. Tobias-Machado M, Correa TD, De Barros EL, Wroclawski ER. Antibiotic prophylaxis in prostate biopsy. A comparative randomized clinical assay between ciprofloxacin, norfloxacin and chloramphenicol. Int Braz J Urol 2003;29:313-319.
36. Yang L, Hu J, Wei H, et al. Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy. Zhonghua wai ke za zhi [Chinese Journal of Surgery] 2001;39:940-942. Yang 2001a
37. Yang L, Hu J, Wei H, et al. Clinical significance of antibiotic prophylaxis for transrectal prostate biopsy. Zhonghua wai ke za zhi [Chinese Journal of Surgery] 2001;39:940-942. Yang 2001b
38. Chun FK, Epstein JI, Ficarra V, et al. Optimizing performance and interpretation of prostate biopsy: A critical analysis of the literature. Eur Urol 2010;58:851-864.
39. Loeb S, Carter HB, Berndt SI, et al. Complications after prostate biopsy: Data from SEER-Medicare. J Urol 2011;186: 1830-1834.
40. Liss MA, Chang A, Santos R, et al. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol 2011;185:1283-1288.
41. Lange D, Zappavigna C, Hamidizadeh R, et al. Bacterial sepsis after prostate biopsy-a new perspective. Urology 2009;74:1200-1205.
42. Adibi M, Hornberger B, Bhat D, et al. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. J Urol 2013; 189:535-540.
43. Ho HS, Ng LG, Tan YH, et al. Intramuscular gentamicin improves the efficacy of ciprofloxacin as an antibiotic prophylaxis for transrectal prostate biopsy. Ann Acad Med Singapore 2009;38:212-216.
44. Horcajada JP, Busto M, Grau S, et al. High prevalence of extended-spectrum beta-lactamase-producing enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: A need for changing preventive protocol. Urology 2009;74:1195-1199.
45. Kehinde EO, Al-Maghrebi M, Sheikh M, Anim JT. Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate. J Urol 2013;189:911-915.
46. Rumaihi KA, Majzoub AA, Younes N, Shokeir A. Does intravenous cefuroxime improve the efficacy of ciprofloxacin for preventing infectious complications after transrectal prostate biopsy? A prospective comparative study. Arab J Urol 2012;10:388-393.
47. Shen PF, Zhu YC, Wei WR, et al. The results of transperineal versus transrectal prostate biopsy: A systematic review and meta-analysis. Asian J Androl 2012;14:310-315.
48. Pu C, Bai Y, Yuan H, et al. Reducing the risk of infection for transrectal prostate biopsy with povidone-iodine: A systematic review and meta-analysis. Int Urol Nephrol 2014; 46:1691-1698.
49. Siriboon S, Tiengrim S, Taweemongkongsup T, et al. Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand. Urol Int 2012;88:187-193.
50. Lundstrom K, Drevin L, Carlsson S, et al. Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy. J Urol 2014;192:1116-1122.